Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUNAR: Sotrovimab in Immunocompromised Non-hospitalized COVID-19 Patients
NCT05305651Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2022
- Primary completion
- Jul 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of sotrovimab in coronavirus disease 2019 (COVID-19), sponsored by GSK. Started Jul 2022; status: completed.
02
Drugs
sotrovimab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05305651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05305651.